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One of the challenges of physicians in practicing evidence-based medicine lies in judging whether the treatment effects estimated in empirical studies are indeed applicable to the patients he or she encounters in daily clinical practice or even to an individual patient. Moreover, the treatment effects may be modified by certain patient characteristics (i.e., vary across patient subgroups). Patients and clinicians will thus benefit from knowledge on which patient characteristics should be taken into account in the decision to initiate treatment. Such knowledge on relevant subgroup effects will enable treatment decisions to be individualized as much as possible (1) (2) (3) .
Subgroup analyses can be valuable when there is consensus that a clinically relevant subgroup is studied in an appropriate way. However, when subgroup analyses are underpowered or analyzed in an incorrect way, they can lead to incorrect conclusions, that is, false positive or false negative results. As such, treatment may be either withheld from those most likely to benefit or targeted at a subgroup of patients unlikely to profit from it (4-7). Currently, inappropriate subgroup analyses are common (4) (5) (6) (7) (8) . It has been especially suggested that investigators who are disappointed by their initial overall negative findings search for subgroups of patients in whom the treatment is beneficial after all (9, 10) .
Several publications have observed the problem of reporting inappropriate subgroup analyses (4, 7, (11) (12) (13) (14) . However, when properly planned, reported, and interpreted, subgroup analyses can provide valuable information (15) . One of the most important recommendations of the available guidelines is to prespecify subgroups rather than define them post hoc. Publications so far on the pros and cons of subgroup analyses, however, are based on published studies only (4, 8, 11, 13, (15) (16) (17) (18) (19) (20) (21) (22) , and therefore the authors were unable to establish whether subgroup analyses were indeed prespecified in the design of the study or reported in only the methods section of an article. We had the unique opportunity to study both grant proposals and their final reports and publications to compare the subgroup analyses that were prespecified in the grant proposal with those that were finally published.
MATERIALS AND METHODS

Grant applications and scientific publications
All grants awarded by the Health Care Efficiency Research Program of the Netherlands Organization for Health Research and Development (ZonMw) (i.e., the Dutch ''National Institutes of Health'') from 2001 were eligible for inclusion in this study. They were included when the final report (i.e., a report for the program committee in which researchers provide their results to confirm that they have met the grant conditions) was received by ZonMw before March 1, 2010.
The grant applications and final reports were retrieved from the ZonMw office. PubMed was used to search for the related scientific publications, with the last search on June 1, 2010.
We used standardized, pilot-tested forms to extract the following data: study design, type of research, sample size, length of follow-up, research institute, primary and secondary outcomes, the number of scientific publications, and the presence of a question regarding the diversity of the study population (in the grant application form and/or the final report). With regard to the subgroup analyses, the following characteristics were extracted: number, type, stage of the process first mentioned, justification, methods used, power calculation for that specific subgroup, and the results (both the overall effect estimate and the subgroup results).
The type of research was categorized as one of the following: intervention, diagnostic, prognostic, or other. We classified 5 types of subgroups: patient characteristics (e.g., age, gender, or ethnicity); disease characteristics (e.g., severity); intervention characteristics (e.g., dose or adjuvant interventions); household characteristics (e.g., socioeconomic status, smoking, or family history); and other characteristics. The justification for the subgroup analyses was categorized as literature, clinical experience, biologic mechanism, or no justification at all.
Statistical analysis
We first analyzed whether or not projects mentioned subgroups in their grant application and their related publications (i.e., both the final report and the scientific publications). The main outcome measure was the proportion of studies in which the publications were completely in agreement with the grant proposal; that is, subgroups that were prespecified in the grant proposal were reported and no new subgroup analyses were introduced in the publications. For this main outcome measure, we also performed stratified analysis per type of research (i.e., interventions studies vs. other types of research) and research design (randomized controlled trials vs. other designs).
Second, we compared published study protocols with the grant proposal and final publications.
Of all individual subgroups that could be identified in the included projects, we analyzed if they were first mentioned in the grant application (i.e., prespecified) or in the publications (i.e., post-hoc finding). Prespecified subgroups were defined as any subgroup mentioned in the grant application; neither the categories of the subgroup variable nor the direction or outcome had to be specified. We also calculated the percentage of subgroup analyses performed on nonsignificant or inconclusive overall effect estimates.
A subgroup analysis was defined as significant when the researchers reported a significant effect by either 1) providing a significant P value for the interaction test and/or 2) reporting the results of the stratified analyses, whereby confidence intervals differed significantly between the subgroups, and/or 3) stating that there was a significant subgroup effect without providing the actual numerical values.
All data were analyzed anonymously with SPSS, version 15 (SPSS, Inc., Chicago, Illinois), by using descriptive and comparative statistics. Continuous variables were presented as medians and ranges and/or interquartile ranges. Categorical and dichotomous variables were presented as proportions.
RESULTS
Of the 79 projects that could be evaluated, the majority were intervention studies (63.3%), followed by diagnostic (22.8%), prognostic (7.6%), and other (6.3%) studies (Table 1) . Most projects comprised randomized controlled trials (59.5%), and almost all were conducted at a university or university medical center (93.7%). Sixty-four projects (81.0%) mentioned at least one subgroup during any stage of the process from grant application to final report and/or scientific publications.
In 20 of the 79 projects (25%), the final publications were in agreement with the grant proposal; that is, subgroups that were prespecified in the grant proposal were reported and no new subgroup analyses were introduced in the publications. Figure 1 shows that 49 (62%) and 53 (67%) projects mentioned subgroups in their grant application and related publications (i.e., final report and/or scientific publications), respectively. Only 5 of the 49 projects (10.2%) that specified subgroups in their grant application reported on exactly the same subgroups in their publications. Eleven of the 49 projects (22.4%) with intended subgroup analyses did not report on subgroups at all, whereas the other 33 projects (67.3%) added and/or omitted subgroups in the publications. Half of the 30 studies that did not prespecify any subgroup did report subgroups in their publications. When restricted to the 8 studies that justified at least one of their subgroups in the grant proposal, 1 (12.5%) did not report on subgroups at all, whereas the other 7 (87.5%) added extra subgroups in the publications; 4 (50.0%) also omitted subgroups in the publications.
For 21 of the 79 studies, a published protocol was available, and 13 (62%) of these were completely similar to the grant proposal regarding the planned subgroup analyses. When we compared the 21 published protocols with the scientific publication, 8 (38%) were completely similar regarding the planned and reported subgroup analyses. This percentage is somewhat higher than the 25% of the grant proposals that were in complete agreement with the scientific publications.
In 11 of the 50 (22%) intervention studies, the final publications were in agreement with the grant proposal and, for the other studies, this was 9 out of 29 (31%). When stratified on design, agreement was seen in 11 of the 47 randomized controlled trials (23%) and in 9 of the 32 remaining designs (28%).
Within the 64 projects that did report on subgroups, a total of 292 subgroups were identified. Only 46 (30.9%) of the 149 a priori (i.e., in the grant application) specified subgroups were also reported in either the final report and/or the publication. Of the 189 subgroups reported in either the final report or publication, 143 (75.6%) were post-hoc findings (i.e., first introduced in the report or publications). For 77% of the subgroup analyses reported in the scientific publications, it was not mentioned whether they were based on either prespecified subgroup analyses or post-hoc findings.
Eighty-five of the 120 (70.8%) subgroup analyses in the scientific publications were performed on a nonsignificant or inconclusive overall effect estimate, whereas 35 (29.2%) were performed on a significant overall effect estimate. Of the subgroup analyses performed on nonsignificant or inconclusive results, 20 became significant (23.5%); of those performed on a significant overall result, 34.4% remained significant.
In 6 of the 36 (17%) studies that reported on subgroups in their scientific publications, subgroup analyses were performed on a ''new'' primary outcome, that is, not the one mentioned in the grant proposal, and in 3 studies (8%), subgroup analyses were performed on a ''new'' secondary outcome. Table 2 shows the characteristics of subgroup analyses mentioned during the process from grant application to final publications on the project level. More than 80% of the projects did not justify any of their subgroups, but if justified it was mostly based on literature. Interaction tests, which are recommended to study subgroup effects (6), were not reported in the grant application at all and in only 4 (9%) final reports and 8 (22%) scientific publications.
None of the final reports or scientific publications reported exact details regarding the interaction tests used. In 3 of the 4 final reports that used interaction tests, subgroup effects were reported only for significant interaction tests; the other final report reported all subgroup effects, including those with a nonsignificant interaction test. In 2 of the 8 scientific publications that used interaction tests, the results of the interaction tests were not presented. Two other scientific publications reported both significant and nonsignificant results on the interaction test. The last 4 scientific publications that used interaction tests reported only nonsignificant interaction tests.
DISCUSSION
To our knowledge, we are the first to compare subgroup analyses as outlined in grant proposals with those included in final publications. In 25% of the projects, the final publications were in complete agreement with the grant proposal (i.e., subgroups that were prespecified in the grant proposal were reported and no new subgroup analyses were introduced in the publications). Only 31% of the subgroups that were prespecified in the grant proposal were reported in the final report or publication, and 76% of the finally reported subgroup effects were post-hoc findings. Justification of subgroup analysis, the statistical methods used, and power calculations were very rarely reported.
Two-thirds of the projects in our study reported on subgroups in their final publication, which is in agreement with most reviews that have been performed so far in which the proportion of subgroups ranged from 57% to 70% (4, 7, 11, 15, (18) (19) (20) 22) . The number of subgroups reported in our study ranged from 1 to 16, with a median of 2. In previous studies, the median number of subgroups ranged from 2 to 4 (4, 7, 11, 17) , and the maximum number of subgroups ranged from 15 up to 50 (4, 7, 11, 12, 17, 19) . Other studies also found that justification of subgroup analyses, the methods used to perform subgroup analyses, and power calculations for performing subgroup analyses are often not reported (4, 7, 8, 11, 12, 15-19, 21, 22) . Nineteen percent of the projects included in our study justified at least one of the subgroups on which they report in the scientific literature. This is in line with other studies performed so far that also found that clinical or scientific justification is rare (8, 11, 12, 16) . Sixty-one percent of our studies reported a statistical method for at least one of their subgroup analyses; 36% used the interaction test (22% of total), and 77% used stratified analyses (47% of total). Most studies performed so far focused on the use of the interaction test, and the proportion of studies that used the interaction test for at least one of their subgroups ranged from 10% to 56% (4, 7, 8, 11, 12, 15-19, 21, 22) , which is comparable with our findings. So far, only 3 studies have mentioned the power of the subgroup analyses; all reported that the studies were underpowered for detecting subgroup effects (4, 11, 21) . This is in agreement with our findings that, in only 5% of the studies with a scientific publication, a power calculation was performed for one of the reported subgroups.
Several potential limitations of our study should also be taken into consideration. First, scientific publications regarding the final results were not (yet) available for all projects because some projects were only finished recently (n ¼ 14), and others were discontinued because of recruitment problems (n ¼ 5). A comparison of the grant proposals and final reports of the completely finished (i.e., with scientific publication) projects and those without the scientific publication did not show large differences. Bias due to missing publications is therefore unlikely. Second, reporting bias cannot be precluded; that is, subgroup effects in scientific publications might be influenced by the opinions of reviewers and editors. We did not, however, find large differences between the final reports, which are due to time constraints mostly written before the scientific publication, and the scientific publications. We therefore think that reporting bias is also unlikely. Third, in the analyses we pooled the data of different types of research (e.g., diagnostic and therapeutic research) and study designs (e.g., randomized controlled trials and cohort studies). Because the analyses might differ, we also performed sensitivity analyses stratified for type of research and study design, which showed similar results. We therefore decided that pooling was indeed allowed. Fourth, our results might not be directly generalizable to other countries or grant-awarding organizations as each grant-awarding organization has its Abbreviation: IQR, interquartile range; NA, not applicable. a Grant application consists of the following: preproposal, official grant application, and rebuttal. b As percentage of those studies that mentioned a subgroup anywhere in the process (n ¼ 64). c Total number can be higher than the total number of studies, as all subgroups in the same stage of the process were combined but where type, justification, and method were mentioned for each subgroup separately.
own standards. However, the process of a peer-review grant application process will very likely be the same for all organizations. Fifth, as most studies mentioned multiple subgroups, a clustering effect may occur for reporting on justification and methods. We therefore reported the results on project instead of individual subgroup level.
Furthermore, the implications for practice are still unclear, because we do not know how often reported subgroups led to incorrect conclusions, with the potential consequence that treatment is either withheld from those most likely to benefit or that the treatment is targeted at a subgroup of patients unlikely to profit from it. We also do not know yet whether the subgroup results will be implemented in daily practice.
Despite all the recommendations available regarding the prespecification, justification, and methods for subgroup analyses (4, 5, (14) (15) (16) (23) (24) (25) (26) (27) (28) (29) (30) , the items are still underreported. The development of one, generally accepted, guideline for performing subgroup analyses should therefore be encouraged. This guideline should then be implemented in guidelines regarding the quality improvement of such publications as the Consolidated Standards of Reporting Trials (CONSORT), the Standards for the Reporting of Diagnostic Accuracy Studies (STARD), and the Quality of Reporting of Meta-Analyses Standards (QUOROM), as this seems the only option to really improve the analysis, reporting, and claim of subgroup effects in clinical research.
In conclusion, there is a large discrepancy between the grant applications and the final publications regarding subgroup analyses. Both nonreporting prespecified subgroup analyses and reporting post-hoc subgroup analyses are common. More guidance is clearly needed.
